Table 1.
Cell types | Role of AIM2 | References |
---|---|---|
Macrophages | AIM2 inflammasome activation leads to antimicrobial host immune responses | 3, 4, 5, 27, 28, 33 |
AIM2 inflammasome over‐activation leads to abnormal functional maturation of macrophages thereby facilitating the progression of SLE | ||
AIM2 inflammasome activation leads to high levels of IL‐18 secretion from Kupffer cells thereby promoting hepatic NK cell activity and increasing NK cell‐dependent IFN‐γ | ||
Induction caspase 1‐mediated cleavage of cGAS thereby upregulating PD‐L1 and IDO, which inhibit antibody‐dependent cellular cytotoxicity and T cell‐mediated cytotoxicity to evade the adaptive response | ||
DCs | AIM2 inflammasome activation leads to antimicrobial host immune responses | 34, 35, 36, 37 |
AIM2 inflammasome participates in the process of CD137L‐mediated monocyte to DC differentiation | ||
AIM2 inflammasome activation leads to high levels of IL‐1α production thereby promoting lung cancer cell proliferation | ||
Neutrophils | Expression of key components of AIM2 inflammasome | 38 |
T cells | Induction antigen‐specific antibody response thereby enhancing adaptive immunity of CD8+ T cells | 39, 40, 41, 42, 43 |
Upregulation of AIM2 in Treg restrain autoimmune diseases by reducing AKT–mTOR signaling and a T cell‐intrinsic role | ||
B cells | Upregulation of AIM2 in gastric B cells inhibits CXCL16 production in the control of infiltration and retention of CD8+ T cells within chronic inflammatory tissues | 44, 45 |
Upregulation of AIM2 preferential in mature memory CD27+ B cells of adults | ||
Downregulation of AIM2 by FOXP1 in mature human B cells |
Abbreviations: AIM2, absent in melanoma 2; DCs, dendritic cells; IFN‐γ, interferon γ; IL, interleukin; SLE, systemic lupus erythematosus.